Absetz, P., et al. ‘Type 2 Diabetes Prevention in the Real World: Three-Year Results of the GOAL Lifestyle Implementation Trial’. Diabetes Care, vol. 32, no. 8, Aug. 2009, pp. 1418–20, https://doi.org/10.2337/dc09-0039.
Ackermann, Ronald T., et al. ‘Translating the Diabetes Prevention Program into the Community’. American Journal of Preventive Medicine, vol. 35, no. 4, Oct. 2008, pp. 357–63, https://doi.org/10.1016/j.amepre.2008.06.035.
Carter, Patrice, et al. ‘Dietary Recommendations for the Prevention of Type 2 Diabetes: What Are They Based On?’ Journal of Nutrition and Metabolism, vol. 2012, 2012, pp. 1–6, https://doi.org/10.1155/2012/847202.
Chiasson, Jean-Louis, et al. ‘Acarbose for Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Randomised Trial’. The Lancet, vol. 359, no. 9323, June 2002, pp. 2072–77, https://doi.org/10.1016/S0140-6736(02)08905-5.
Church, T. S., et al. ‘Exercise Capacity and Body Composition as Predictors of Mortality Among Men With Diabetes’. Diabetes Care, vol. 27, no. 1, Jan. 2004, pp. 83–88, https://doi.org/10.2337/diacare.27.1.83.
Colberg, S. R., et al. ‘Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: Joint Position Statement Executive Summary’. Diabetes Care, vol. 33, no. 12, Dec. 2010, pp. 2692–96, https://doi.org/10.2337/dc10-1548.
Cordain, L., et al. ‘Physical Activity, Energy Expenditure and Fitness: An Evolutionary Perspective’. International Journal of Sports Medicine, vol. 19, no. 05, July 1998, pp. 328–35, https://doi.org/10.1055/s-2007-971926.
DeFronzo, Ralph A., et al. ‘Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance’. New England Journal of Medicine, vol. 364, no. 12, Mar. 2011, pp. 1104–15, https://doi.org/10.1056/NEJMoa1010949.
Dyson, P. A., et al. ‘Diabetes UK Evidence-Based Nutrition Guidelines for the Prevention and Management of Diabetes’. Diabetic Medicine, vol. 28, no. 11, Nov. 2011, pp. 1282–88, https://doi.org/10.1111/j.1464-5491.2011.03371.x.
‘Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events’. New England Journal of Medicine, vol. 362, no. 16, Apr. 2010, pp. 1463–76, https://doi.org/10.1056/NEJMoa1001122.
‘Effect of Valsartan on the Incidence of Diabetes’. New England Journal of Medicine, vol. 363, no. 8, Aug. 2010, pp. 792–93, https://doi.org/10.1056/NEJMc1005899.
Frank W. Booth. ‘Waging War on Modern Chronic Diseases: Primary Prevention through Exercise Biology’. Journal of Applied Physiology, vol. 88, no. 2, 2000, pp. 774–87, http://jap.physiology.org/content/88/2/774.
Gillies, C. L., et al. ‘Pharmacological and Lifestyle Interventions to Prevent or Delay Type 2 Diabetes in People with Impaired Glucose Tolerance: Systematic Review and Meta-Analysis’. BMJ, vol. 334, no. 7588, Jan. 2007, pp. 299–299, https://doi.org/10.1136/bmj.39063.689375.55.
Gray, Laura J., et al. ‘Defining Obesity Cut-Off Points for Migrant South Asians’. PLoS ONE, vol. 6, no. 10, Oct. 2011, https://doi.org/10.1371/journal.pone.0026464.
Greaves, Colin J., et al. ‘Systematic Review of Reviews of Intervention Components Associated with Increased Effectiveness in Dietary and Physical Activity Interventions’. BMC Public Health, vol. 11, no. 1, 2011, https://doi.org/10.1186/1471-2458-11-119.
Hamman, R. F., et al. ‘Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes’. Diabetes Care, vol. 29, no. 9, Sept. 2006, pp. 2102–07, https://doi.org/10.2337/dc06-0560.
Laaksonen, D. E., et al. ‘Physical Activity in the Prevention of Type 2 Diabetes: The Finnish Diabetes Prevention Study’. Diabetes, vol. 54, no. 1, Jan. 2005, pp. 158–65, https://doi.org/10.2337/diabetes.54.1.158.
Lindstrom, J., et al. ‘The Finnish Diabetes Prevention Study (DPS): Lifestyle Intervention and 3-Year Results on Diet and Physical Activity’. Diabetes Care, vol. 26, no. 12, Dec. 2003, pp. 3230–36, https://doi.org/10.2337/diacare.26.12.3230.
Norris, Susan L., et al. ‘Long-Term Non-Pharmacological Weight Loss Interventions for Adults with Prediabetes’. Cochrane Database of Systematic Reviews, John Wiley & Sons, Ltd, 1996, https://doi.org/10.1002/14651858.CD005270.
‘Nutrition Recommendations and Interventions for Diabetes: A Position Statement of the American Diabetes Association’. Diabetes Care, vol. 31, no. Supplement 1, Jan. 2008, pp. S61–78, https://doi.org/10.2337/dc08-S061.
Pan, X. R., et al. ‘Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study’. Diabetes Care, vol. 20, no. 4, Apr. 1997, pp. 537–44, https://doi.org/10.2337/diacare.20.4.537.
Public Health England - Diabetes Prevention Programmes: Evidence Review. Public Health England, 2015, https://www.gov.uk/government/publications/diabetes-prevention-programmes-evidence-review.
Ramachandran, A., et al. ‘The Indian Diabetes Prevention Programme Shows That Lifestyle Modification and Metformin Prevent Type 2 Diabetes in Asian Indian Subjects with Impaired Glucose Tolerance (IDPP-1)’. Diabetologia, vol. 49, no. 2, Feb. 2006, pp. 289–97, https://doi.org/10.1007/s00125-005-0097-z.
‘Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin’. New England Journal of Medicine, vol. 346, no. 6, Feb. 2002, pp. 393–403, https://doi.org/10.1056/NEJMoa012512.
Schwarz, Peter E., et al. ‘Nonpharmacological Interventions for the Prevention of Type 2 Diabetes Mellitus’. Nature Reviews Endocrinology, Jan. 2012, https://doi.org/10.1038/nrendo.2011.232.
Schwarz, Peter E. H., et al. ‘Development and Implementation of A European Guideline and Training Standards for Diabetes Prevention-The IMAGE Project’. Journal of Public Health, vol. 15, no. 5, Sept. 2007, pp. 353–60, https://doi.org/10.1007/s10389-007-0145-x.
Schwarz, Peter E. H. ‘Public Health Implications: Translation into Diabetes Prevention InitiativesâFour-Level Public Health Concept’. Medical Clinics of North America, vol. 95, no. 2, Mar. 2011, pp. 397–407, https://doi.org/10.1016/j.mcna.2010.11.008.
‘Screening for Type 2 Diabetes: Literature Review and Economic Modelling’. Clinical Governance: An International Journal, vol. 12, no. 4, Oct. 2007, https://doi.org/10.1108/cgij.2007.24812dae.003.
Steven N Blair. ‘Physical Inactivity: The Biggest Public Health Problem of the 21st Century’. British Journal of Sports Medicine, vol. 43, Jan. 2009, pp. 1–2, http://bjsm.bmj.com/content/43/1/1.full.
TELFORD, RICHARD D. ‘Low Physical Activity and Obesity: Causes of Chronic Disease or Simply Predictors?’ Medicine & Science in Sports & Exercise, vol. 39, no. 8, http://ezproxy.lib.le.ac.uk/login?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00005768-200708000-00005&LSLINK=80&D=ovft.
The Relative Importance of Modifiable Potential Risk Factors of Type 2 Diabetes: A Meta-Analysis of Two Cohorts. http://link.springer.com/article/10.1007/s10654-009-9405-0/fulltext.html.
Tuomilehto, Jaakko, et al. ‘Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance’. New England Journal of Medicine, vol. 344, no. 18, May 2001, pp. 1343–50, https://doi.org/10.1056/NEJM200105033441801.
Umpierre, Daniel. ‘Physical Activity Advice Only or Structured Exercise Training and Association With HbA Levels in Type 2 Diabetes’. JAMA, vol. 305, no. 17, May 2011, https://doi.org/10.1001/jama.2011.576.
Yates, T., et al. ‘Effectiveness of a Pragmatic Education Program Designed to Promote Walking Activity in Individuals With Impaired Glucose Tolerance: A Randomized Controlled Trial’. Diabetes Care, vol. 32, no. 8, Aug. 2009, pp. 1404–10, https://doi.org/10.2337/dc09-0130.
Yates, T, et al. ‘The Role of Physical Activity in the Management of Type 2 Diabetes Mellitus’. Postgraduate Medical Journal, vol. 85, no. 1001, Mar. 2009, pp. 129–33, https://doi.org/10.1136/pgmj.2008.067900.
Yates, Thomas, et al. ‘Stand up for Your Health: Is It Time to Rethink the Physical Activity Paradigm?’ Diabetes Research and Clinical Practice, vol. 93, no. 2, Aug. 2011, pp. 292–94, https://doi.org/10.1016/j.diabres.2011.03.023.
